retatrutide fat loss trial Side Effects: What Patients Should Know Retatrutide NEW Phase 3 Clinical

The growing popularity of GLP-1 weight-loss injections is raising concerns about increased gallstone risk, medical experts warn

For example, the UK SmPCs for liraglutide (Saxenda) and semaglutide (Wegovy/Ozempic), available via the Electronic Medicines Compendium (eMC), advise awareness of heart rate increases during treatment and recommend that clinicians consider discontinuation if a clinically relevant sustained rise in resting heart rate is observed

Bodybuilding or cosmetic use is a separate concern

Your prescriber will review your past medical history when prescribing Semaglutide to check it is suitable for you